MedPath

The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer

Completed
Conditions
Prostate Cancer
Registration Number
NCT00496249
Lead Sponsor
University Health Network, Toronto
Brief Summary

Many younger men are diagnosed with prostate cancer. These patients are often choosing radiation therapy as their primary treatment. The effect of this therapy on fertility will have a direct impact on their decision about therapeutic options and fertility preservation. The researchers hypothesize that when patients are treated with radiation for localized prostate cancer, infertility can occur due to direct damage to seminiferous tubules affecting sperm quality.

Detailed Description

Prostate cancer is the most common malignant disease among men. Many young men are diagnosed with localized prostate cancer. Some of these men are choosing to manage their prostate cancer with radiation therapy. The radiation therapy delivers minimal dose exposure to adjacent organs. We hypothesize that when patients are treated with radiation therapy for localized prostate cancer, decreased fertility can occur due to damage of seminiferous tubules, which may affect sperm quality. This study will assess the impact of radiation therapy on semen and seminal fluid.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
19
Inclusion Criteria
  • Subjects with histologically confirmed low risk to moderate stage prostate cancer (Gleason 6 - 7) treated with brachytherapy or external beam radiation
  • > 12 months ago
Read More
Exclusion Criteria
  • Subjects with a prior history of infertility
  • Subjects who have undergone vasectomy
  • Subjects who have received LHRH therapy for prostate cancer < 6 months ago
  • Subjects who have received anti-androgens < 3 months ago
  • Subjects using alpha blockers within 7 days of specimen provision
  • Subjects who have taken finasteride or dutasteride within the previous 4 months.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Health Network

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath